Nuformix

NFX: 5.75 -0.25 (-4.17%) delayed: 26 Feb 2020, 13:08

Trade now
Bid Price 5.50 High Price 6.00
Ask Price 6.00 Low Price 5.50
Open Price 5.92 Spread 8.33%
Prev Close 6.00 Volume 1,945,139

Nuformix Share Price

Intraday
Historic - 6 months
>> Advanced Nuformix Charts >>

Nuformix Share Price Information

Name Nuformix
Epic NFX
Sector Biotechnology
ISIN GB00BYW79Y38
Activites Nuformix plc (formerly Leverrett plc) is a pharmaceutical development company using cocrystal technology to unlock the therapeutic potential of approved small molecule drugs. Nuformix's risk-mitigated development strategy has resulted in a pipeline of discoveries through which it has developed and patented novel cocrystal forms of approved small molecules. Nuformix has created an IP portfolio of granted patents covering cocrystal forms of five small molecule drugs. Nuformix is targeting high-value unmet needs with its lead programmes in oncology supportive care: NXP001 and fibrosis: NXP002.
Index n/a
Latest Share Price (p) 5.75 Net Gearing (%) 17.61
Market Capitalisation (£m) 29.41 Gross Gearing (%) 17.69
Shares in issue (m) 490.15 Debt Ratio 0.00
P/E Ratio -16.67 Debt-to-Equity Ratio 0.00
Total dividends per share (p) 0.00 Assets / Equity Ratio 1.22
Dividend Yield (%) 0.00 Price to book value 7.70
Dividend Cover 0.00 ROCE (%) -48.17
Earning per share (p) -0.36 EPS Growth (%) 26.53
52-week high / low (p) 14.75 / 2.00 DPS Growth (%) n/a

Nuformix Director Deals

Date Director Type Volume / Price Trade Value
05 Feb 2020 Dr David Tapolczay Sell 650,000 @ 8.70p £56,550.00
28 Sep 2018 Kirk Siderman-Wolter Buy 35,364 @ 2.60p £919.46
>> More Nuformix Director Deals >>

Nuformix News

>> More Nuformix News >>